CDK Global has successfully renewed its DMS agreement with Sonic Automotive, securing a key partnership following two ...

Genentech’s parent company Roche said the $850m deal lines up with its plan to focus on three therapeutic areas including ...

RHHBY has strengthened its pipeline with an agreement to acquire Regor's portfolio of next-generation CDK inhibitors for the treatment of breast cancer.

In Hybrids amidst financial challenges. Read More CDK Global extends DMS contract with Sonic Automotive amid cyberattack ...

Charting, Price Performance, News & Related Contracts.

Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth ...

Nereus Finance, a pioneering derivatives trading platform, is excited to announce the launch of its newest trading feature: ...

We suggest that future therapeutic strategies targeting the oncogenic network of CDK4/6, MEK, PD-L1, and FOXM1 represent ...

Charting, Price Performance, News & Related Contracts.

Genentech to buy Regor's portfolio of next-generation CDK inhibitors to treat breast cancer: Cambridge, Massachusetts Tuesday, October 1, 2024, 10:00 Hrs [IST] Regor Pharmaceutica ...

Tim Pearson, one of the most Mayor Eric Adams’ influential advisers, has submitted a letter of resignation less than a week after the mayor was indicted on ...